Mask use during high impact exercise in the pandemic

Background: The use of masks is one of the measures to protect against the Covid-19 pandemic. The type of mask and how to use it during physical exercise has generated controversy. This work aims to analyse the effect of the use of masks in the practice of high intensity physical exercise.

Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study.

BACKGROUND AND PURPOSE: Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection is associated with hypercoagulability. We sought to evaluate the demographic and clinical characteristics of cerebral venous thrombosis among patients hospitalized for coronavirus disease 2019 (COVID-19) at 6 tertiary care centers in the New York City metropolitan area. MATERIALS AND METHODS: We conducted a retrospective multicenter cohort study of 13,500 consecutive patients with COVID-19 who were hospitalized between March 1 and May 30, 2020. RESULTS: Of 13,500 patients with COVID-19, twelve had imaging-proved cerebral venous thrombosis with an incidence of 8.8 per 10,000 during 3 months, which is considerably higher than the reported incidence of cerebral venous thrombosis in the general population of 5 per million annually. There was a male preponderance (8 men, 4 women) and an average age of 49 years (95% CI, 36-62 years; range, 17-95 years). Only 1 patient (8%) had a history of thromboembolic disease. Neurologic symptoms secondary to cerebral venous thrombosis occurred within 24 hours of the onset of the respiratory and constitutional symptoms in 58% of cases, and 75% had venous infarction, hemorrhage, or both on brain imaging. Management consisted of anticoagulation, endovascular thrombectomy, and surgical hematoma evacuation. The mortality rate was 25%. CONCLUSIONS: Early evidence suggests a higher-than-expected frequency of cerebral venous thrombosis among patients hospitalized for COVID-19. Cerebral venous thrombosis should be included in the differential diagnosis of neurologic syndromes associated with SARS-CoV-2 infection.

TCT CONNECT-223 Effects of the COVID-19 Pandemic on a Population Older Than 75 Years With Previous Percutaneous Coronary Revascularization: Subanalysis of the SIERRA 75 Registry

Background: In the coronavirus disease-2019 (COVID-19) pandemic, elderly people with cardiovascular risk factors and/or cardiovascular disease have been the most seriously affected. We sought to evaluate the impact of the pandemic, due to both the social confinement and the infection itself, in the population of patients older than 75 years of age with previous percutaneous coronary revascularization. Methods: A subgroup of patients from the SIERRA 75 registry were included in the study. This is a prospective registry of patients older than 75 years undergoing percutaneous revascularization in 42 centers in Spain and Portugal. The follow-up of the patients has been updated, covering the entire period of outbreak and confinement (March 14–May 10, 2020) through direct telephone contact to carry out a specific questionnaire for patients and their relatives. In addition, all electronic health records have been reviewed. Results: A total of 709 patients have been included, of whom 17 had died in the 12.5 ± 3.4 months follow-up before the start of the outbreak and lockdown. Therefore, 692 patients were followed during the study period (mean age of 80.8 ± 4.2 years, 37% women). During this period, 11 (1.6%) had confirmed COVID-19 (age 81.2 ± 5 years, 36% women) of which 8 were admitted to the hospital but none in the intensive care unit. Among the 11 cases, 2 (18%) died, an 80-year-old man and a 76-year-old woman, both in Hospital. COVID-19 incidence was higher than in the global population in the region (1.6% vs. 0.4%;p < 0.0001). During this period of confinement, 91 patients (13%) presented cardiac symptoms (21 stable angina, 82 dyspnea, and 6 syncope). Medical attention was demanded by 43 (6.2%), of whom 22 were admitted in hospitals. There were 4 cases with acute coronary syndrome and 4 underwent revascularization. Death was reported in 7 (1%) patients (2 due to COVID-19, 4 due to cardiovascular disease, and 1 due to multiple pathologies). The monthly mortality rate in this period was 2.6 times higher than in the previous months. Outpatient visits were canceled in 119 cases (17%) but 108 were contacted by phone. Conclusion: In this elderly population with coronary artery disease revascularized before the pandemic, an increase in cardiovascular and general morbidity as well as in total mortality was observed during the outbreak and confinement period. Incidence of COVID-19 was higher than in the general population. Mortality among COVID-19 patients was very high. Categories: OTHER: COVID-19

TCT CONNECT-216 Effects of the COVID-19 Pandemic on a Population Older Than 75 Years With Previous Percutaneous Coronary Revascularization: Experience in Spain and Portugal

Background: In the COVID-19 pandemic, elderly people with cardiovascular risk factors and/or cardiovascular disease have been the most seriously affected. We sought to evaluate the impact of the pandemic, due to both the social confinement and the infection itself, in the population of patients older than 75 years of age with previous percutaneous coronary revascularization. Methods: A subgroup of patients from the SIERRA 75 registry were included in the study. This is a prospective registry of patients older than 75 years undergoing percutaneous revascularization in 42 centers in Spain and Portugal. The follow-up of the patients has been updated, covering the entire period of outbreak and confinement (March 14 to May 10) through direct telephone contact to carry out a specific questionnaire for patients and their relatives. In addition, all electronic health records have been reviewed. Results: A total of 709 patients have been included. Among those, 17 had died in the 12.5 ± 3.4 months follow-up prior to the start of the outbreak-confinement period. Therefore, 692 patients were followed during the study period: (mean age of 80.8 ± 4.2 years, 37% were women, 83% with hypertension, 44% with diabetes, 75% with previous STEMI/NSTEMI, 100% with previous PCI). During this period, 11 (1.6%) had confirmed COVID-19 (age 81.2 ± 5 years, 36% women). Eight were admitted to the hospital but none in the ICU. Among the 11 cases, 2 (18%) died, an 80-year-old man and a 76-year-old woman, both in the hospital. COVID-19 incidence was higher than in the global population in the region (1.6% vs. 0.4%;p < 0.0001). During this period of confinement, 91 patients (13%) presented cardiac symptoms (21 stable angina, 82 dyspnea and 6 syncope). Medical attention was demanded by 43 (6.2%), of whom 22 were admitted to the hospital. There were 4 (0.6%) cases with acute coronary syndrome and 4 (0.6%) underwent revascularization. Death was reported in 7 (1%) patients (2 due to COVID-19, 4 due to cardiovascular disease, and 1 due to multiple pathologies). The monthly mortality rate in this period was 2.6 times higher than in the previous months. Outpatient visits were canceled in 119 cases (17%) but 108 were contacted by phone. Conclusion: In this elderly population with coronary artery disease revascularized before the pandemic, an increase in cardiovascular and general morbidity as well as in total mortality was observed during the outbreak and confinement. Incidence of COVID-19 was higher than in the general population. Mortality among COVID-19 patients was very high. Categories Other: COVID-19